Capital Research Global Investors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,623,900
Closed -$312M 438
2017
Q1
$312M Buy
6,623,900
+5,165
+0.1% +$246K 0.1% 186
2016
Q4
$318M Buy
+6,618,735
New +$304M 0.1% 180
2015
Q1
Sell
-229,449
Closed -$11.1M 451
2014
Q4
$11.1M Sell
229,449
-2,395,470
-91% -$114M ﹤0.01% 417
2014
Q3
$126M Hold
2,624,919
0.04% 275
2014
Q2
$130M Buy
2,624,919
+57,222
+2% +$2.68M 0.05% 267
2014
Q1
$121M Hold
2,567,697
0.04% 270
2013
Q4
$123M Buy
2,567,697
+2,395,470
+1,391% +$107M 0.05% 263
2013
Q3
$7.21M Buy
+172,227
New +$7.42M ﹤0.01% 434

Other funds holding MET

Capital Research Global Investors's MET Position: Q2 2017 in Review

Capital Research Global Investors sold out of MetLife (MET) in Q2 2017, closing a stake of 6,623,900 shares — an estimated $312M sold.

Capital Research Global Investors first reported a position in MET in Q3 2013 and held it in 8 quarters. The position peaked at $318M in Q4 2016. 1,030 funds tracked by Wall St. Rank hold MET as of Q2 2017.

  • Capital Research Global Investors reported no remaining MetLife position as of Q2 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 6,623,900 MetLife shares in Q2 2017, an estimated $312M.
  • Capital Research Global Investors first reported a position in MetLife in Q3 2013 and held it in 8 quarters.
  • Capital Research Global Investors's MetLife position peaked at $318M in Q4 2016.
  • 1,030 funds tracked by Wall St. Rank held MetLife as of Q2 2017.

Based on Capital Research Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.